Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
451
datasets available to search
ShareScore release 0.9.0
Dataset results
451 results for “AMD”
A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT04480463. IPD Sharing: NO. Countries: 14. Publications: 0.
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
ClinicalTrials.gov study NCT00913744. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD
ClinicalTrials.gov study NCT04626128. IPD Sharing: NO. Countries: 1. Publications: 0.
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
ClinicalTrials.gov study NCT03322930. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal
ClinicalTrials.gov study NCT01115556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMD
ClinicalTrials.gov study NCT01243645. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD
ClinicalTrials.gov study NCT03953079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Sildenafil on Choroidal Thickness in AMD
ClinicalTrials.gov study NCT01830790. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00964795. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD
ClinicalTrials.gov study NCT02214628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT06190093. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD
ClinicalTrials.gov study NCT01021956. IPD Sharing: NO. Countries: 2. Publications: 0.
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
ClinicalTrials.gov study NCT01482910. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00275821. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD
ClinicalTrials.gov study NCT04690556. IPD Sharing: NO. Countries: 7. Publications: 0.
Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT02418754. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD
ClinicalTrials.gov study NCT00527423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device
ClinicalTrials.gov study NCT01103505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
ClinicalTrials.gov study NCT01414153. IPD Sharing: NO. Countries: 1. Publications: 0.
The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot
ClinicalTrials.gov study NCT00605423. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.